Form 4: MiNK Therapeutics CEO Sells Shares
Insider Transaction (Form 4)
Jennifer Buell, Chief Executive Officer and a Director of MiNK Therapeutics, Inc., sold 6,938 shares of common stock on October 11, 2026 for $10.56 per share.
Summary
- Option exercise/conversion: acquired 23,191 Common Stock on October 11, 2026; holds 81,133 after (Direct).
- Open-market sale: disposed of 6,938 Common Stock at $10.56 ($73,265) on October 12, 2026; holds 74,195 after (Direct).
- Option exercise/conversion: disposed of 23,191 Restricted Stock Units on October 11, 2026; holds 46,382 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $73,265 of stock on the open market.
Insider Transactions
Jennifer Buell — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-11 | Option exercise/conversion | Common Stock | 23,191 | — | — | 81,133 |
| 2026-10-12 | Open-market sale | Common Stock | 6,938 | $11 | $73.3K | 74,195 |
| 2026-10-11 | Option exercise/conversion | Restricted Stock Units | 23,191 | — | — | 46,382 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-11 | Option exercise/conversion (23,191 shares) |
| 2026-10-12 | Open-market sale (6,938 shares) |
| 2026-10-11 | Option exercise/conversion (23,191 shares) |
Keywords
insider transaction, Form 4, INKT, MiNK Therapeutics, Inc., bearish, Jennifer Buell
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.